Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine and Octreotide for Relapsed Low-Grade Non-Hodgkin's Lymphoma
NCT00002779Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 1998
- Primary completion
- Jul 2000
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of octreotide in Indolent Non-Hodgkin Lymphoma (INHL), sponsored by Cancer and Leukemia Group B. Started Feb 1998; status: completed.
02
Drugs
octreotide
03
Conditions
Indolent Non-Hodgkin Lymphoma (INHL)
Beyond the preview
Go deeper on NCT00002779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002779.